Tiwari Vishvanath, Khokhar Manoj
Department of Biochemistry, Central University of Rajasthan, Ajmer 305801, Rajasthan, India.
Department of Biochemistry, Central University of Rajasthan, Ajmer 305801, Rajasthan, India.
Eur J Pharmacol. 2014 Oct 15;741:156-70. doi: 10.1016/j.ejphar.2014.07.048. Epub 2014 Aug 21.
Coronary artery disease is one of the leading causes of death worldwide. One of the significant causes of this disease is hypercholesterolemia which is the result of various genetic alterations that are associated with the accumulation of specific classes of lipoprotein particles in plasma. A number of drugs are used to treat hypercholesterolemia like statin, fibrate, bile acid sequestrants, niacin, ezetimibe, omega-3 fatty acids and natural extracts. It has been observed that these drugs show diverse response in different individuals. The present review explains the mechanism of action of these drugs as well as mechanism of its lesser effectiveness or resistance in some individuals. There are various identified genetic variations that are associated with diversity in the drugs response. Therefore, present study helps to understand the ethiology of drug mechanism and resistance developed against drugs used to treat hypercholesterolemia.
冠状动脉疾病是全球主要死因之一。这种疾病的一个重要病因是高胆固醇血症,它是由各种基因改变导致的,这些改变与特定类别的脂蛋白颗粒在血浆中的积累有关。许多药物用于治疗高胆固醇血症,如他汀类药物、贝特类药物、胆汁酸螯合剂、烟酸、依泽替米贝、ω-3脂肪酸和天然提取物。据观察,这些药物在不同个体中表现出不同的反应。本综述解释了这些药物的作用机制以及在某些个体中疗效较差或产生耐药性的机制。有各种已确定的基因变异与药物反应的多样性有关。因此,本研究有助于了解药物作用机制的病因以及针对治疗高胆固醇血症药物产生的耐药性。